Scientists have reached a critical point in the development of new therapies for prostate cancer. The information gleaned from the Human Genome Project, alongside the emergence of new technologies for the use of genetic data has expanded the physician’s understanding of disease progression and widened his armamentarium for prostate cancer prevention and control.
This expertlywritten reference thoroughly analyzes the scientific principles and methodologies behind the most recent translational therapies and provides the necessary context, data, and studies for practitioners to select appropriate candidates for treatment and effectively apply new therapies in clinical practice.
Autores: A. Dawson Nancy, W. Kevin Kelly
Editorial: Informa Healthcare